LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Ubiquigent Ltd.
Headquarters:
Dundee, Scotland, United Kingdom
Website:
http://www.ubiquigent.com
Year Founded:
2009
Status:
Private
BioCentury
|
Mar 12, 2024
Deals
Deal report: Boehringer-Sosei pursuing new schizophrenia target
Plus: Gilead- Merus to develop trispecific T cell engagers for cancer, and Armatus-Solid collab
Read More
BioCentury
|
Aug 29, 2023
Management Tracks
Crossover-backed Arbor names Tamboli CFO
Plus: Atkinson named chief technical operations officer at Vertex, and updates from Confo, Flagship, Citryll and more
Read More
BioCentury
|
Nov 8, 2022
Management Tracks
BMS’ Rutstein joins Daiichi as head of oncology
Plus new CMO at Boehringer Ingelheim, and updates from Repertoire, Atsena, TAAV and more
Read More
BioCentury
|
Feb 20, 2021
Product Development
BMS turns to mechanistic diversity in early oncology pipeline
BMS has holes to fill with upcoming patent expirations
Read More
BioCentury
|
Aug 17, 2018
Financial News
Ubiquigent raises undisclosed venture round
Read More
BioCentury
|
Nov 24, 2014
Company News
Ubiquigent, University of Dundee deal
Read More
BioCentury
|
Nov 10, 2014
Company News
Ubiquigent board of directors update
Read More
BioCentury
|
Sep 23, 2013
Financial News
Ubiquigent completes venture financing
Read More
BioCentury
|
Mar 8, 2010
Financial News
Ubiquigent completes venture financing
Read More
Items per page:
10
1 - 9 of 9
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help